AMS on NYSE
AMERICAN SHARED HOSPITAL SERVICES
Price unavailable
Last updated Oct 18, 2026.
Overview
Compare with OpGen (United States), Psychemedics Corporation or Exagen Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
18.0%Gross margin3
-12.8%Operating margin3
-5.5%Net margin3
-0.9%Revenue growth, 20253
-6.5%Return on equity3
0.00×Debt to equity3
-$4.5MFree cash flow3
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Products and services
Patient Income brought in 32% of the revenue AMERICAN SHARED HOSPITAL SERVICES broke down this way in fiscal 2025.
Products and services by year
| Products and services | 2024 | 2025 |
|---|---|---|
| Patient Income | $12.6M | $15.5M |
| Medical Equipment Leasing | $15.8M | $12.6M |
| Rental Income from Medical Services | $15.6M | $12.6M |
| PBRT Services | $10.0M | $7.4M |
Business segments
Direct Patient Services brought in 55% of the revenue AMERICAN SHARED HOSPITAL SERVICES broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Direct Patient Services | $12.6M | $15.5M |
| Medical Equipment Leasing | $15.8M | $12.6M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Cost of revenue72¢$23.0M
- Selling, general and admin22¢$7.1M
- Interest5¢$1.6M
- Income tax2¢$493.0K
Out of $28.1M in revenue.3 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Capital spending100¢$7.6M
Out of $3.1M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.3
Financial statements
Every line of the income statement in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Revenues | $28.1M | $28.3M |
| Maintenance and supplies | $2.8M | $2.3M |
| Depreciation and amortization | $5.7M | $6.1M |
| Other direct operating costs | $13.6M | $10.1M |
| Other direct operating costs, related party | $978.0K | $678.0K |
| Cost of Revenue | $23.0M | $19.2M |
| Gross margin | $5.1M | $9.2M |
| Selling and administrative expense | $7.1M | $7.4M |
| Interest expense | $1.6M | $1.5M |
| Loss on write down of impaired assets | $0 | $3.1M |
| Operating loss | -$3.6M | -$2.8M |
| Business Combination, Bargain Purchase, Gain Recognized, Amount | $0 | $3.8M |
| Interest and other income, net | $368.0K | $248.0K |
| (Loss) income before income taxes | -$3.2M | $1.2M |
| Income tax benefit | -$493.0K | -$295.0K |
| Net (loss) income | -$2.7M | $1.5M |
| (Plus): net loss attributable to non-controlling interests | $1.2M | $654.0K |
| Net (loss) income attributable to American Shared Hospital Services | -$1.6M | $2.2M |
| (Loss) earnings per common share - basic (in dollars per share) | -$0.23 | $0.34 |
| (Loss) earnings per common share - diluted (in dollars per share) | -$0.23 | $0.33 |
| Weighted average common shares for basic (loss) earnings per share (in shares) | 6.6M shares | 6.5M shares |
| Weighted average common shares for diluted (loss) earnings per share (in shares) | 6.6M shares | 6.7M shares |
Every line of the balance sheet in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Cash and cash equivalents | $3.5M | $11.0M | |
| Restricted cash | $250.0K | $250.0K | |
| Accounts receivable, net of allowance for credit losses of $980,000 and $265,000 at December 31, 2025 and December 31, 2024, respectively | $10.5M | $11.6M | |
| Tax receivables | $978.0K | $550.0K | |
| Other receivables | $1.0M | $391.0K | |
| VAT credits | $702.0K | $112.0K | |
| Prepaid maintenance | $12.0K | $1.4M | |
| Prepaid expenses and other current assets | $774.0K | $928.0K | |
| Total current assets | $17.7M | $26.3M | |
| PROPERTY AND EQUIPMENT, net | $31.1M | $31.1M | |
| LAND | $1.3M | $19.0K | |
| GOODWILL | $1.3M | $1.3M | |
| INTANGIBLE ASSETS | $78.0K | $78.0K | |
| RIGHT OF USE ASSETS, net | $3.6M | $1.0M | |
| OTHER ASSETS | $341.0K | $437.0K | |
| TOTAL ASSETS | $55.5M | $60.2M | |
| Accounts payable | $607.0K | $1.6M | |
| Employee compensation and benefits | $1.5M | $1.4M | |
| Other accrued liabilities | $1.8M | $1.9M | |
| Asset retirement obligations, related party (includes $250,000 and $250,000 non-related party at December 31, 2025 and 2024, respectively) | $1.2M | $1.2M | |
| Current portion of lease liabilities | $150.0K | $226.0K | |
| Current portion of long-term debt, net | $17.3M | $2.8M | |
| Total current liabilities | $23.4M | $10.4M | |
| LONG-TERM LEASE LIABILITIES, less current portion | $4.2M | $1.5M | |
| LONG-TERM DEBT, net, less current portion | $0 | $17.3M | |
| DEFERRED INCOME TAXES | $115.0K | $924.0K | |
| TOTAL LIABILITIES | $27.8M | $30.2M | |
| Common stock, no par value (10,000,000 authorized shares; Issued and outstanding shares 6,575,000 at December 31, 2025 and 6,420,000 at December 31, 2024) | $10.8M | $10.8M | |
| Additional paid-in capital | $9.0M | $8.6M | |
| Retained earnings | $4.3M | $5.8M | |
| Total equity- American Shared Hospital Services | $24.0M | $25.2M | |
| Non-controlling interests in subsidiaries | $3.7M | $4.8M | |
| Total shareholders equity | $27.7M | $30.0M | $26.3M |
| TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY | $55.5M | $60.2M | |
| Allowance for doubtful accounts | $980.0K | $265.0K | |
| Asser retirement obligations, non-related party | $250.0K | $250.0K | |
| Common stock, no par value (in dollars per share) | $0 | $0 | |
| Common stock, shares authorized (in shares) | 10.0M shares | 10.0M shares | |
| Common stock, shares issued (in shares) | 6.6M shares | 6.4M shares | |
| Common stock, shares outstanding (in shares) | 6.6M shares | 6.4M shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.3
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net (loss) income | -$2.7M | $1.5M |
| Depreciation and amortization | $5.7M | $6.2M |
| Non cash lease expense | $331.0K | $228.0K |
| Accretion of deferred issuance costs | $126.0K | $95.0K |
| Loss on write down of impaired assets | $0 | $3.1M |
| Gain on sale of equipment | $0 | -$155.0K |
| Bargain purchase gain RI Acquisition, net of deferred income taxes | $0 | -$3.8M |
| Deferred income taxes | -$809.0K | -$359.0K |
| Accretion of unfavorable lease position | -$26.0K | -$65.0K |
| Stock-based compensation | $404.0K | $373.0K |
| Receivables | -$559.0K | -$6.9M |
| Prepaid expenses and other assets | $1.7M | -$513.0K |
| Asset retirement obligations, related party | $0 | -$588.0K |
| Related party liabilities | $207.0K | $324.0K |
| Lease liability | -$285.0K | -$228.0K |
| Accounts payable and accrued liabilities | -$955.0K | $2.2M |
| Income taxes payable | $0 | -$1.2M |
| Net cash provided by operating activities | $3.1M | $167.0K |
| Payment for purchases of property and equipment | -$7.6M | -$7.9M |
| Cash received in excess of cash paid for RI Acquisition | $0 | $538.0K |
| Proceeds from sale of equipment | $0 | $295.0K |
| Net cash used in investing activities | -$7.6M | -$7.1M |
| Principal payments on long-term debt | -$3.0M | -$2.7M |
| Principal payments on line of credit | -$9.0M | -$13.4M |
| Advances on line of credit | $9.0M | $10.9M |
| Long-term debt financing on purchase of property and equipment | $0 | $9.9M |
| Debt issuance costs long-term debt | $0 | -$164.0K |
| Distributions to non-controlling interests | -$21.0K | -$95.0K |
| Capital contributions from non-controlling interests | $8.0K | $38.0K |
| Net cash (used in) provided by financing activities | -$3.0M | $4.4M |
| Net change in cash and cash equivalents | -$7.6M | -$2.5M |
| Cash paid for interest | $1.4M | $1.4M |
| Cash paid for income taxes | $739.0K | $1.8M |
| Equipment included in accounts payable and accrued liabilities | $400.0K | $990.0K |
| Increase in ARO obligation | $0 | $1.1M |
Compare AMERICAN SHARED HOSPITAL SERVICES with another company
Recent filings
- Aug 13, 20268-K
- Aug 13, 202610-Q
- Jul 30, 2026SCHEDULE 13D/A
- Jul 28, 20268-K
- Jul 24, 20264
- Jul 16, 20263
- Jul 13, 20268-K
- Jun 30, 20268-K
- Jun 25, 2026SCHEDULE 13D/A
- Jun 24, 20264
- Jun 23, 2026SCHEDULE 13D/A
- Jun 4, 20268-K
- May 14, 20268-K
- May 14, 202610-Q
- May 7, 2026DEFA14A
Every filing from the last three years, summarized. The full record is on SEC EDGAR.1
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10